In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Fetal Bovine Serum market for 2018-2023.
This report studies the Fetal Bovine Serum market, Fetal bovine serum is the remained blood fraction after the natural coagulation of blood, which is obtained by centrifugation to remove any remaining red blood cells.
The raw material of fetal bovine serum is fetal bovine blood. The FBS suppliers make contract with beef processer or agent and gather fetal bovine blood at certain time. The production of FBS is quite seasonal because the raw material source can only be acquired twice a year. The primary factor and main market-driver is the beef processing industry, since FBS is produced as a byproduct of this industry. Since 2014, the price of FBS has been raising quickly due to multiple factors, among which, the climate change and reduced cattle inventory might be the most important ones.
The primary application of FBS is to fortify cell culture media. It is the most common media supplement used for cell culture. Considering end use, the application of FBS can be classified as scientific research and industrial production. The development of biomedical and healthcare industry has been witnessed with rapid development for the past years. Consequently, though sera industry has experienced substantial changes for the past years, the demand of FBS has been creeping. We estimate that FBS would not be replaced by substitute in short time, but suppliers in emerging market are in taking an increasing share, like Lanzhou Minhai and Zhejiang Tianhang Biotechnology.
Over the next five years, LPI(LP Information) projects that Fetal Bovine Serum will register a 8.4% CAGR in terms of revenue, reach US$ 1450 million by 2023, from US$ 890 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Fetal Bovine Serum market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Segmentation by application:
This report also splits the market by region:
Middle East & Africa
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Tissue Culture Biologicals
Bio Nutrientes Brasil
Zhejiang Tianhang Biotechnology
Jin Yuan Kang
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
To study and analyze the global Fetal Bovine Serum consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Fetal Bovine Serum market by identifying its various subsegments.
Focuses on the key global Fetal Bovine Serum manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Fetal Bovine Serum with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Fetal Bovine Serum submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their